Search


	Podcast:		BioCentury This Week
	Episode:		Ep. 241 - U.K. Biopharma on the Move. Plus: IRA, Biosecure
	Category:		Science & Medicine
	Duration:		00:18:45
	Publish Date:		2024-07-09 00:00:00
	Description:		The U.K.’s life sciences ecosystem boasts “palpable energy at the very innovation end of the spectrum in biotech, with a lot of really quality science,” BioCentury Editor in Chief Simone Fishburn says on the latest BioCentury This Week podcast. Fishburn assesses the maturation of the country’s biotech industry, including the need for an influx of capital to catalyze the sector’s growth. Washington Editor Steve Usdin discusses the latest developments for the Inflation Reduction and the Biosecure acts as well as the benefits of the breakthrough therapy pathway. Also on BioCentury.com, listeners may want to check out Danielle Golovin’s analysis of LNP innovation and Paul Bonanos’ take on Monday’s $3.2 billion M&A move by Eli Lilly. This episode of BioCentury This Week was sponsored by Nxera Pharma. View full story: https://www.biocentury.com/article/652898 00:01 - Sponsor Message: Nxera Pharma 01:24 - U.K. Biopharma 08:14 - IRA 10:28 - Biosecure Act 14:49 - Breakthrough Designation Pathway
	Total Play:		0